Seaver Autism Center

Search results

• ORYZON reports results and corporate update for quarter ended March 31, 2021

  Joseph Buxbaum

  7/05/21

  1 item of Media coverage

  Press/Media

• ORYZON Reports Results and Corporate Update for Quarter Ended March 31, 2021

  Joseph Buxbaum

  7/05/21

  13 items of Media coverage

  Press/Media

• SFARI April 2021 announcements: Updates to SFARI’s 2021 requests for grant applications, SFARI 2020 Director Awards and more

  Joseph Buxbaum

  5/05/21

  1 item of Media coverage

  Press/Media

• ORYZON Starts Preclinical Collaboration on Autism with the Seaver Autism Center at Mount Sinai

  Joseph Buxbaum

  6/04/21 → 7/04/21

  10 items of Media coverage

  Press/Media

• Oryzon Genomics Enters into Collaboration with Icahn School of Medicine at Mount Sinai

  Joseph Buxbaum

  7/04/21

  1 item of Media coverage

  Press/Media

• ORYZON Initiates Preclinical Collaboration on Autism with Seaver Autism Center at Mount Sinai

  Joseph Buxbaum

  6/04/21

  1 item of Media coverage

  Press/Media

• Oryzon Genomics S A : starts preclinical collaboration on autism with the Seaver Autism Center at Mount Sinai

  Joseph Buxbaum

  6/04/21

  2 items of Media coverage

  Press/Media

• Autism answers within genetic disorders

  Joseph Buxbaum

  25/02/21

  1 item of Media coverage

  Press/Media

• icahn school of medicine at mount sinai transcript request - JN Auto

  Hala Harony-Nicolas

  5/02/21

  1 item of Media coverage

  Press/Media

• NeuCyte and Mount Sinai Enter Collaboration Agreement

  Joseph Buxbaum

  19/01/21

  10 items of Media coverage

  Press/Media

• Mount Sinai and Rumi Scientific Team Up to Advance Drug Discovery for Rare Genetic Disorders Tied to Autism

  Joseph Buxbaum

  6/01/21 → 8/01/21

  4 items of Media coverage

  Press/Media

• Mount Sinai and Rumi Scientific join hands to initiate autism drug discovery pipeline

  Joseph Buxbaum

  7/01/21

  2 items of Media coverage

  Press/Media

• Mount Sinai and Rumi Scientific team up to advance autism drug discovery

  Joseph Buxbaum

  6/01/21

  1 item of Media coverage

  Press/Media

• Celebrating Excellence and Inclusiveness in Neuroscience

  Eric Nestler & Drew Kiraly

  5/11/20

  1 item of Media coverage

  Press/Media

• A Loving Big Sister Helping the World

  Alexander Kolevzon

  5/11/20

  1 item of Media coverage

  Press/Media

• The BRAIN Foundation Opens Synchrony 2020 on Nov. 1, Supported by Caltech, Highlighting a Program on Basic Research and Animal Model Research in ASD

  Joseph Buxbaum

  29/10/20

  1 item of Media coverage

  Press/Media

• Mount Sinai Doctors Elected to National Academy of Medicine for Contributions to Emergency Medicine and Translational Genetics

  Eric Nestler, Ramon Parsons,, Brendan Carr, Joseph Buxbaum, Kenneth L. Davis & Albert Siu

  19/10/20

  3 items of Media coverage

  Press/Media

• Healthcare-Associated Legionnaires' Disease, Europe, 2008-2017.(SYNOPSIS)

  Sven S. Sandin

  1/10/20

  1 item of Media coverage

  Press/Media

• Researchers shed new light on epigenetic changes associated with ADNP syndrome

  Silvia De Rubeis

  6/08/20

  1 item of Media coverage

  Press/Media

• Epigenetic Changes in ADNP Syndrome, a Cause of Autism, Do Not Indicate Profound Presentation of the Disorder

  Silvia De Rubeis

  5/08/20

  3 items of Media coverage

  Press/Media

• Mount Sinai Health System: Epigenetic Changes in ADNP Syndrome, a Cause of Autism, Do Not Indicate Profound Presentation of the Disorder

  Silvia De Rubeis

  5/08/20

  1 item of Media coverage

  Press/Media

• Seaver Autism Center For Research and Treatment at Mount Sinai Launches First Drug Trial for ADNP Syndrome

  Alexander Kolevzon & Joseph Buxbaum

  7/07/20

  2 items of Media coverage

  Press/Media

• $ALKS Alkermes Announces 3rd Annual ALKERMES PATHWAYS RESEARCH AWARDS℠ Program and 2019 Recipients

  Michael Breen

  29/06/20

  1 item of Media coverage

  Press/Media

• 'Remarkable' Lack of Genetic Testing in Autism

  Alexander Kolevzon

  19/05/20

  1 item of Media coverage

  Press/Media

• Clinical Trial: Low-Dose Ketamine in Children With ADNP Syndrome

  Alexander Kolevzon

  15/05/20

  2 items of Media coverage

  Press/Media